Weight Loss Drugs Like Ozempic, Wegovy May Help Fight Alcoholism and Opioid Addiction
A new study reveals that glucagon-like peptide-1 receptor agonists (GLP-1), which include weight loss and diabetes meds Ozempic, Wegovy, Mounjaro or Zepbound, may help users overcome alcoholism and opioid addiction.
Study: GLP-1 weight-loss drugs might lower, not increase, teen suicide risk
In a new study, obese kids who used GLP-1 weight-loss drugs had a 33% decline in their risk for thoughts of suicide and suicide attempts compared to adolescents who didn't.
Weight loss drugs like Ozempic may help reduce overdose risks: Study
A study suggests that weight loss medications like Ozempic may help reduce the risk of overdose and alcohol intoxication in people with substance use disorders.
Can Weight Loss Drugs Also Treat Addiction?
GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and alcohol intoxication, a large real-world study suggested.
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
Weight-Loss Drugs Cut Drug and Alcohol Abuse, According to New Study
Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence that the drugs yield health benefits beyond diabetes and weight loss.
Ozempic shows promise for treating alcohol and drug abuse, study finds
The weight-loss drugs are linked with reduced rates of excess drinking and opioid overdoses, suggesting they may tamp down substance use cravings too.
Ozempic may help battle drug and alcohol addiction
Weight-loss drugs like Ozempic and Mounjaro, which also treat diabetes, may help users battling drug and alcohol abuse as well. A study published in the Addiction medical journal Wednesday showed roughy 1.
Ozempic could help with opioid and alcohol abuse, new research shows
A new study published Thursday found that groundbreaking weight loss and diabetes medications also combat opioid-use disorder and alcohol misuse disorder. This is the second study this fall to suggest that GLP-1s,
Scientists Discover Amazing New Benefit of Ozempic: Reducing Alcohol and Opioid Addiction
New research shows that Ozempic and similar drugs reduce opioid overdoses by 40% and alcohol intoxication by 50% in people with substance use disorders. These medications, often prescribed for diabetes and weight issues,
Ozempic and other weight loss drugs could help treat alcohol and drug addiction, study says
The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.
New weight loss drugs raise questions of access, costs
New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...
News Medical on MSN2d
Expanding access to GLP-1 weight-loss drugs could save thousands of lives
Researchers estimate that expanding access to weight-loss drugs could save over 50,000 lives annually, reducing obesity rates ...
Healthline1d
Ozempic Microdosing Is Gaining Popularity. Does It Work for Weight Loss?
What health experts think of the growing Ozempic “microdosing” trend that claims taking very small doses of GLP-1 drugs can ...
GLP-1 Stocks Aren't the Only Way to Benefit From the Weight Loss Drugs Boom
However, GLP-1-based therapies aren't going to be the only option in the weight loss medicines market forever. Some companies ...
Not Many Employers Cover GLP-1 Weight Loss Drugs
Fewer than 20% of large employers are covering GLP-1 weight loss drugs like Ozempic, a new KFF analysis shows.